Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Breast Cancer Research and Treatment|October 4, 2000
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II studyG Frasci, G D'Aiuto, P Comella, et al.Breast Cancer Research and Treatment|August 7, 1998
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II studyG Frasci, P Comella, G D'Aiuto, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2005
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trialP Comella, B Massidda, G Filippelli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2009
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908G Frasci, G D'Aiuto, P Comella, et al.Clinical Lung Cancer|January 22, 2004
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group StudyP Comella, N Panza, L Manzione, et al.Breast Cancer Research and Treatment|November 26, 1999
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology GroupG Frasci, G D'Aiuto, P Comella, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trialP Comella, F De Vita, S Mancarella, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)P Comella, G Filippelli, G De Cataldis, et al.Pageof 9